Shares of Hemogenyx Pharmaceuticals PLC (LON: HEMO) today surged 1.7% revering a 4-day downtrend that has been in place ever since the company announced that it had secured a £60 million financing deal with Mint Capital Limited.
The company’s shares rallied for two days after announcing the deal, which allows it to issue up to £60 million in unsecured convertible loan notes to Mint Capital and to use the funds raised at its own discretion.
Hemonegynx has seen its shares fall erasing all the gains made over the initial two days as investors sold their shares, in what can be best described as the market’s disapproval of the financing deal.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
The biotechnology company continues to raise money while reporting minimal progress with its various therapies.
Investors may also be worried about the fact that none of the company’s potential treatments has started clinical trial as both its immunotherapy and cell therapy treatments are still in the preclinical stages.
Hemogenyx is expected to issue the first tranche of notes worth £12 million to Mint Capital to help accelerate and broaden its development pipeline of novel therapies and treatments for blood cancers and viral diseases.
The financing will also strengthen the Company’s negotiating position with both existing and future partners.
However, the company must get approval from shareholders before issuing the loans and must publish a prospectus and submit it to the UK’s FCA for approval beforehand.
Hemogenyx share price
Hemogenyx shares today surged 1.7% to hit a high of 8.34p having rallied from Wednesday’s closing price of 8.20p.
People who read this also read:
